Summary by Moomoo AI
On August 12, 2024, Safety Shot, Inc., a wellness and dietary supplement company, announced the results of a clinical trial that demonstrated its product's ability to significantly reduce Blood Alcohol Content (BAC) in consumers. The trial, conducted by The Center for Applied Health Sciences (CAHS), was a double-blind, randomized, placebo-controlled study that showed a 30%-50% faster reduction in BAC when participants consumed Safety Shot compared to a placebo. The participants, aged 24 to 46, experienced not only a rapid decrease in BAC but also reported less head discomfort, reduced fatigue, and improved concentration. The company's COO, David Sandler, highlighted the decade of research and development behind the product, which is now clinically proven to aid in the rapid reduction of alcohol...Show More